Advances in solid drug nanoparticle technologies have resulted in a number of long-acting
(LA) formulations with the potential for once monthly or longer administration. Such …

Women often have limited access to contraception, and barrier methods have low
acceptance and a high failure rate, mostly due to incorrect use, which can result in …

This article presents a comprehensive review on controlled release hormonal contraceptive
systems that include transdermal patches, intravaginal rings (IVRs), intrauterine devices …

Development of injectable, long‐lasting, contraceptive drug delivery formulations, and
implants are highly desired to avoid unplanned pregnancies while improving patient …

The parenteral route of administration is preferred over the oral route for treatment of many
chronic and life-threatening diseases due to better patient compliance. Long-acting …

The study design is that lipophilic drug was encapsulated within dissolving microneedles
(DMNs) for sustained-release delivery over 1 week. Etonogestrel (ENG), the progestogen …

Medical device related infections are a significant and growing source of morbidity and
mortality. Biofilm formation is a common feature of medical device infections that is not …

Hydrophobic drugs wrapped in poly (lactic-co-glycolic acid)(PLGA)-based microneedles
(MNs) require a long time to release completely. To obtain the desired duration, it is still …

This article presents BEPO®, an in situ forming depot (ISFD) technology mediated by a
solvent-exchange mechanism. The matrix of the in situ formed drug delivery depot is …

Poor patient adherence to oral contraceptives is the predominant cause of failure of these
therapies, leading to unplanned pregnancies that can negatively affect female health …